These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20423715)

  • 1. Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model.
    Ichimura R; Mizukami S; Takahashi M; Taniai E; Kemmochi S; Mitsumori K; Shibutani M
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):128-40. PubMed ID: 20423715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of GST-P-positive proliferative lesions facilitating lipid peroxidation with possible involvement of transferrin receptor up-regulation and ceruloplasmin down-regulation from the early stage of liver tumor promotion in rats.
    Mizukami S; Ichimura R; Kemmochi S; Taniai E; Shimamoto K; Ohishi T; Takahashi M; Mitsumori K; Shibutani M
    Arch Toxicol; 2010 Apr; 84(4):319-31. PubMed ID: 20091025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
    Takahashi M; Shibutani M; Woo GH; Inoue K; Fujimoto H; Igarashi K; Kanno J; Hirose M; Nishikawa A
    Carcinogenesis; 2008 Nov; 29(11):2218-26. PubMed ID: 18586688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
    Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
    Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of TMEM70 in Rat Liver Cells After Hepatocarcinogen Treatment Related to the Warburg Effect in Hepatocarcinogenesis Producing GST-P-Expressing Proliferative Lesions.
    Mizukami S; Watanabe Y; Nakajima K; Hasegawa-Baba Y; Jin M; Yoshida T; Shibutani M
    Toxicol Sci; 2017 Sep; 159(1):211-223. PubMed ID: 28903497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.
    Abe H; Ogawa T; Wang L; Kimura M; Tanaka T; Morita R; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):467-74. PubMed ID: 25151969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of low-density lipoprotein receptor class A domain-containing protein 4 (Ldlrad4) in the liver of rats treated with nongenotoxic hepatocarcinogen to induce transforming growth factor β signaling promoting cell proliferation and suppressing apoptosis in early hepatocarcinogenesis.
    Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Okano H; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
    J Appl Toxicol; 2020 Nov; 40(11):1467-1479. PubMed ID: 32596862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
    Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
    Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
    Taniai E; Kawai M; Dewa Y; Nishimura J; Harada T; Saegusa Y; Matsumoto S; Takahashi M; Mitsumori K; Shibutani M
    Cancer Sci; 2009 May; 100(5):813-20. PubMed ID: 19309364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor promotion by copper-overloading and its enhancement by excess iron accumulation involving oxidative stress responses in the early stage of a rat two-stage hepatocarcinogenesis model.
    Mizukami S; Ichimura R; Kemmochi S; Wang L; Taniai E; Mitsumori K; Shibutani M
    Chem Biol Interact; 2010 May; 185(3):189-201. PubMed ID: 20302851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of UBE2E2 in rat liver cells after hepatocarcinogen treatment facilitates cell proliferation and slowing down of DNA damage response in GST-P-expressing preneoplastic lesions.
    Mizukami S; Watanabe Y; Saegusa Y; Nakajima K; Ito Y; Masubuchi Y; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2017 Nov; 334():207-216. PubMed ID: 28899750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models.
    Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M
    Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
    Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
    Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad phospho-isoforms direct context-dependent TGF-β signaling.
    Matsuzaki K
    Cytokine Growth Factor Rev; 2013 Aug; 24(4):385-99. PubMed ID: 23871609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Jin M; Saegusa Y; Kawai M; Umemura T; Shibutani M; Mitsumori K
    Toxicol Sci; 2008 Dec; 106(2):339-49. PubMed ID: 18775883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.
    Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W
    Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.